市場調査レポート

商品コード

1461628

2DPA-1の世界市場規模、シェア、成長分析、用途別、最終用途別-産業予測、2024～2031年

Global 2DPA-1 Market Size, Share, Growth Analysis, By Application(Pharmaceuticals, Agrochemicals), By End Use(Healthcare, Textile & Dye) - Industry Forecast 2024-2031

出版日: 2024年04月02日 | 発行: SkyQuest

| ページ情報: 英文 184 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 830,245円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 971,230円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,112,215円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.65円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の2DPA-1市場規模は、2022年に6,176億1,000万米ドルと評価され、2023年の6,410億8,000万米ドルから2031年には8,639億5,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは3.80％で成長する展望です。

汎用性の高い化合物であるDAPAは、医薬品合成、染料生産、さまざまな工業プロセスにおいて広範な用途を見出しています。2-ジフェニルアセチル-1,3-インダンジオンとしても知られる革新的な化合物である2DPA-1の世界市場は、そのユニークな特性を活かして、この合成化合物に対する多様な産業ニーズに対応しています。需要の高まりに対応するため、世界の2DPA-1市場は、主に医薬、農薬、特殊化学合成の化学中間体として、幅広い用途にこの化合物を供給することに注力しています。さらに、染料、顔料、パーソナルケア製品の製造においても重要な役割を果たしており、老化防止、抗炎症、抗酸化機能が高く評価されています。拡大する世界の2DPA-1市場は、多方面にわたる革新的ソリューションの需要増に対応するため、業界関係者に有利な機会を提供しています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

2DPA-1の世界市場：用途別

市場概要
医薬品
農薬
化粧品
その他

2DPA-1の世界市場：最終用途別

市場概要
医療
繊維・染料
その他

2DPA-1の世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Siemens AG（ドイツ）
GE Healthcare（米国）
Philips Healthcare（オランダ）
Canon Medical Systems Corporation（日本）
Hitachi, Ltd.（日本）
Toshiba Medical Systems Corporation（日本）
Koninklijke Philips N.V.（オランダ）
Fujifilm Holdings Corporation（日本）
Carestream Health, Inc.（米国）
Esaote SpA（イタリア）
Samsung Medison Co., Ltd.（韓国）
Hologic, Inc.（米国）
Mindray Medical International Limited（中国）
Agfa-Gevaert NV（ベルギー）
Shimadzu Corporation（日本）
CurveBeam LLC（米国）
Planmed Oy（フィンランド）
Medtronic plc（アイルランド）
Varian Medical Systems, Inc.（米国）
Epiroc AB（スウェーデン）
Elekta AB（スウェーデン）

Product Code: SQMIG15E2176

Global 2DPA-1 Market size was valued at USD 617.61 billion in 2022 and is poised to grow from USD 641.08 billion in 2023 to USD 863.95 billion by 2031, growing at a CAGR of 3.80% during the forecast period (2024-2031).

The versatile compound DAPA finds extensive application in pharmaceutical synthesis, dye production, and various industrial processes. The global market for 2DPA-1, an innovative chemical compound also known as 2-diphenylacetyl-1,3-indandione, caters to the diverse industrial needs for this synthetic compound with its unique properties. Serving to meet the rising demand, the global 2DPA-1 market focuses on supplying this compound for a broad spectrum of applications, primarily as a chemical intermediate in pharmaceutical, agrochemical, and specialty chemical synthesis. Moreover, it plays a vital role in dye, pigment, and personal care product manufacturing, where its anti-aging, anti-inflammatory, and antioxidant features are highly valued. The expanding global 2DPA-1 market offers lucrative opportunities for industry players to meet the increasing demand for innovative solutions across multiple sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 2DPA-1 Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 2DPA-1 Market Segmental Analysis

Global 2DPA-1 Market is segmented on the basis of application, end user and region. By application, the market is segmented into pharmaceuticals, agrochemicals, cosmetics, and others. By end user, the market is segmented into healthcare, textile & dye, others. By region, the market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 2DPA-1 Market

The pharmaceutical sector tirelessly seeks fresh and inventive drug prospects to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1, encompassing its anti-inflammatory, anti-cancer, and antiviral effects, propel its integration into drug exploration and advancement efforts, consequently fostering a substantial Compound Annual Growth Rate (CAGR) for the worldwide 2DPA-1 market throughout the projected timeframe.

Restraints in the Global 2DPA-1 Market

The arrival of new players in both regional and global markets has the potential to intensify competition, posing a significant threat to established entities. Enhanced product portfolios introduced by competitors can escalate the stakes for existing players, further heightening the competitive landscape.

Market Trends of the Global 2DPA-1 Market

The complexity and expense involved in producing 2DPA-1 could hinder its broad acceptance across industries, potentially restricting its market expansion. Elevated production costs might constrain the availability and affordability of 2DPA-1, thereby impeding its market growth and resulting in a comparatively lower Compound Annual Growth Rate (CAGR) for the global 2DPA-1 market in the projected timeframe.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global 2DPA-1 Market by Application

Market Overview
Pharmaceuticals
Agrochemicals
Cosmetics
Others

Global 2DPA-1 Market by End Use

Market Overview
Healthcare
Textile & Dye
Others

Global 2DPA-1 Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Siemens AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toshiba Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carestream Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esaote SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samsung Medison Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agfa-Gevaert NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CurveBeam LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epiroc AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments